Subcutaneous vs intramuscular peptides

Most peptide protocols on this site specify subcutaneous (SC, subQ, or SQ) injection. A handful — Cerebrolysin, sometimes Tesamorelin in clinical use, occasionally NAD+ — call for intramuscular (IM) injection. The two routes differ in three ways that matter: depth, absorption rate, and technique.

The 60-second summary

Property	Subcutaneous	Intramuscular
Tissue	Fatty layer just under the skin	Muscle below the fat
Needle depth	5–8 mm	15–25 mm
Needle size	31 G × 5/16 in (insulin syringe)	22–25 G × 1 to 1.5 in
Injection angle	90° (or 45° for thin users)	90°
Absorption rate	Slow (30 min – several hours)	Faster (10–30 min)
Volume tolerance	Up to ~1.5 ml comfortably	Up to ~3 ml in larger muscles
Common sites	Abdomen, thigh, upper arm	Deltoid, vastus lateralis, glute
Self-inject difficulty	Easy	Harder
Supplies cost	$0.20/dose (insulin syringe)	$0.60/dose (separate syringe + needle)

Why most peptides use subcutaneous

Three reasons:

1. Sustained absorption. Most peptides — GLP-1 agonists, BPC-157, ipamorelin, GHK-Cu — work through receptor signaling that benefits from a slower, steadier plasma curve rather than a sharp spike.
2. Self-administration safety. Subcutaneous tissue has fewer nerves and blood vessels than muscle. The technique is easier to teach and harder to do wrong.
3. Smaller volumes. Peptide doses are typically under 1 ml. Subcutaneous tissue accommodates that comfortably.

When intramuscular is used

A short list of compounds and contexts where IM is the standard or an acceptable alternative:

• Cerebrolysin — multi-amino-acid neurotrophic preparation, typically 1–5 ml IM daily during a cycle. SC absorption is too slow for the protocol.
• NAD+ (clinically administered) — often given as IM or IV infusion in larger volumes. Subcutaneous works for smaller weekly doses but stings.
• Some testosterone preparations that may be combined with peptide protocols — testosterone esters are usually IM; peptides in the same protocol stay SC. They're given as separate injections.
• Larger-volume nutrient IV-style peptide drips (provider-only) — always IM or IV, never SC.

For the standard peptide protocols on this site (Sema, Tirz, Reta, BPC-157, TB-500, Ipa, CJC, GHK-Cu, MOTS-c, etc.), the answer is subcutaneous unless your provider specifies otherwise.

Pharmacokinetics — what changes with route

The slower absorption from subcutaneous tissue produces a different plasma concentration curve:

• Subcutaneous: lower peak, longer tail. The medication is absorbed gradually as fat-tissue blood vessels move it into circulation.
• Intramuscular: higher peak, shorter tail. Muscle has more blood flow than fat, so absorption is faster.

For a once-weekly compound like Semaglutide, the difference is clinically minor — the half-life is so long that the absorption-rate difference is dwarfed by total exposure. For an acute-action compound like PT-141 or Cerebrolysin, the route can change the perceived effect.

Subcutaneous sites — the standard set

Same as the insulin sites:

• Abdomen — best general default. 2 inches from navel in any direction. Most consistent absorption.
• Front of thigh — middle of upper third. Slightly slower absorption than abdomen.
• Back of upper arm — over triceps. Hard to self-inject.
• Hip / upper buttocks — slowest absorption.

Rotate every dose. Keep at least 1 inch between consecutive injection points to prevent lipohypertrophy.

Intramuscular sites — different rules

IM is more anatomically demanding because you have to avoid major nerves and blood vessels. The three standard self-injection sites:

• Deltoid (upper arm) — outer arm, ~3 finger-widths below the shoulder bone. Smallest muscle of the three; max ~1 ml volume.
• Vastus lateralis (outer thigh) — middle of the upper-outer thigh, midway between knee and hip. Largest accessible muscle for self-injection; up to 3 ml comfortable.
• Ventrogluteal (side of hip) — palm on hip bone, fingers spread; injection in the V between fingers. Cleaner than the upper-buttock dorsogluteal because no major nerves.

Avoid the dorsogluteal (upper buttock) site for self-injection — it's near the sciatic nerve and historically the most-cited source of injection injuries.

Aspiration — yes for IM, no for SC

For intramuscular injections, the historical practice is to aspirate — pull back slightly on the plunger after the needle is in, to check for blood (which would indicate the needle is in a vessel rather than muscle). If blood appears, withdraw and re-inject at a different spot.

For subcutaneous injections, aspiration is not necessary and generally not done. The fat layer has so few large vessels that the risk doesn't justify the extra step.

Volume limits

Push too much liquid into too small a tissue volume and the medication leaks back out at the puncture, painfully distends the tissue, or absorbs erratically:

Site	Comfortable max volume
Subcutaneous abdomen	1.5 ml
Subcutaneous thigh / arm	1 ml
Deltoid (IM)	1 ml
Vastus lateralis (IM)	3 ml
Ventrogluteal (IM)	3 ml

For peptide protocols, you almost never approach these limits — most doses are 0.05–0.5 ml. The exceptions are NAD+ (often 1+ ml) and Cerebrolysin (1–5 ml in some protocols).

Switching routes

Some users ask whether they can switch a protocol from IM to SC because they find SC easier. The answer is no without provider clearance. The dose is calibrated to the route's pharmacokinetics. A Cerebrolysin protocol designed around IM absorption may produce sub-therapeutic levels at the same volume given subcutaneously.

If you're considering a route change for any reason — pain, bruising, needle phobia, time constraints — bring it up with your provider. Don't decide unilaterally.

Tracking either route in the iOS app

The body-map injection-site tracker handles both. Tap a region (front or back, abdomen / thigh / arm / glute) to log a site. The app records SC vs IM separately and warns about same-region reuse on a recency-weighted basis.

Get the app.

Related reading

• Subcutaneous peptide injection technique — the full SC step-by-step
• Common peptide reconstitution mistakes
• Storing reconstituted peptides
• Reconstitution calculator

References

• MedlinePlus: injection types — NIH overview of administration routes
• PubMed: SC vs IM pharmacokinetics — comparative literature
• American Diabetes Association: injection technique — gold-standard SC technique reference